Trials / Completed
CompletedNCT03980093
The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- University of Colorado, Boulder · Academic / Other
- Sex
- Female
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
This pilot trial compares two online interventions to improve adherence to anti-hormonal medication among women with the most common form of breast cancer (estrogen receptor-positive).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Education | Online medical education on the benefits of anti-hormonal medication, potential side effects, and how to manage them. |
| BEHAVIORAL | Values | An Acceptance and Commitment Therapy (ACT)-based intervention consisting of brief online sessions plus a visual cue-based intervention focused on personal values. |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2020-08-31
- Completion
- 2020-08-31
- First posted
- 2019-06-10
- Last updated
- 2022-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03980093. Inclusion in this directory is not an endorsement.